Nyxoah SA

NYXH.BR·Brussels·Healthcare
Compare
0.8520−0.0280 (−3.18%)today
At close: Oct 21, 5:36 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.8800
Open0.9470
Day range0.85200.9470
52-week range0.77005.1400
Off day high−10.03%
Off 52-week high−83.42%
Volume149.05K
Avg. volume (3M)230.81K
Market cap86.77M
EPS (TTM)-2.19
Forward P/E-1.70
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.00
Shares outstanding101.84M
Short interest—
Earnings dateNov 5, 2026
Analyst target4.4000
Profit margin0.00%

Latest news

All NYXH.BR news ›
MarketScreener·

Nyxoah Names Successor to Outgoing CEO

Nyxoah Chief Executive Officer Olivier Taelman is stepping down after nearly seven years at the helm, according to a Monday release. The obstructive sleep apnea-focused medical technology company... Advanced Medical Equipment & Technology…

MarketScreener·Positive

Nyxoah Names Liam Kelly as Chief Executive

Nyxoah appointed Liam Kelly as chief executive officer, starting Oct. 1, succeeding Olivier Taelman, the company said Monday. Kelly previously served as chairman, president and CEO of Teleflex ... Advanced Medical Equipment & Technology…

From articles in the 4Search news index.

In the news

13mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.